The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

In Vivo Toxicology-Global Market Insights and Sales Trends 2024

In Vivo Toxicology-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1857238

No of Pages : 103

Ask Your Query

Synopsis

In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.

The global In Vivo Toxicology market size is expected to reach US$ 6164 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of In Vivo Toxicology in various end use industries. The expanding demands from the Immunotoxicity, Systemic Toxicity, Carcinogenicity and Genotoxicity, are propelling In Vivo Toxicology market. Chronic Toxicity Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sub-Chronic Toxicity Testing segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for In Vivo Toxicology market, driven by demand from China, the second largest economy with some signs of stabilising, the In Vivo Toxicology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vivo Toxicology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global In Vivo Toxicology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global In Vivo Toxicology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vivo Toxicology sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of In Vivo Toxicology covered in this report include Thermo Fisher Scientific, Danaher, Charles River Laboratories, Labcorp, The Jackson Laboratory, Data Sciences International, Envigo, Eurofins Scientific and Perkinelmer, etc.

The global In Vivo Toxicology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Thermo Fisher Scientific
  • Danaher
  • Charles River Laboratories
  • Labcorp
  • The Jackson Laboratory
  • Data Sciences International
  • Envigo
  • Eurofins Scientific
  • Perkinelmer
  • SRI International
  • Taconic Biosciences
  • Wuxi Apptec

Global In Vivo Toxicology market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global In Vivo Toxicology market, Segment by Type:

  • Chronic Toxicity Testing
  • Sub-Chronic Toxicity Testing
  • Sub-Acute Toxicity Testing
  • Acute Toxicity Testing

Global In Vivo Toxicology market, by Application

  • Immunotoxicity
  • Systemic Toxicity
  • Carcinogenicity
  • Genotoxicity
  • Developmental and Reproductive Toxicity(DART)
  • Other Toxicity Endpoints

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vivo Toxicology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of In Vivo Toxicology
1.1 In Vivo Toxicology Market Overview
1.1.1 In Vivo Toxicology Product Scope
1.1.2 In Vivo Toxicology Market Status and Outlook
1.2 Global In Vivo Toxicology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Vivo Toxicology Market Size by Region (2018-2029)
1.4 Global In Vivo Toxicology Historic Market Size by Region (2018-2023)
1.5 Global In Vivo Toxicology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Vivo Toxicology Market Size (2018-2029)
1.6.1 North America In Vivo Toxicology Market Size (2018-2029)
1.6.2 Europe In Vivo Toxicology Market Size (2018-2029)
1.6.3 Asia-Pacific In Vivo Toxicology Market Size (2018-2029)
1.6.4 Latin America In Vivo Toxicology Market Size (2018-2029)
1.6.5 Middle East & Africa In Vivo Toxicology Market Size (2018-2029)
2 In Vivo Toxicology Market by Type
2.1 Introduction
2.1.1 Chronic Toxicity Testing
2.1.2 Sub-Chronic Toxicity Testing
2.1.3 Sub-Acute Toxicity Testing
2.1.4 Acute Toxicity Testing
2.2 Global In Vivo Toxicology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Vivo Toxicology Historic Market Size by Type (2018-2023)
2.2.2 Global In Vivo Toxicology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Vivo Toxicology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Vivo Toxicology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Vivo Toxicology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Vivo Toxicology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Vivo Toxicology Revenue Breakdown by Type (2018-2029)
3 In Vivo Toxicology Market Overview by Application
3.1 Introduction
3.1.1 Immunotoxicity
3.1.2 Systemic Toxicity
3.1.3 Carcinogenicity
3.1.4 Genotoxicity
3.1.5 Developmental and Reproductive Toxicity(DART)
3.1.6 Other Toxicity Endpoints
3.2 Global In Vivo Toxicology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Vivo Toxicology Historic Market Size by Application (2018-2023)
3.2.2 Global In Vivo Toxicology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Vivo Toxicology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Vivo Toxicology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Vivo Toxicology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Vivo Toxicology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Vivo Toxicology Revenue Breakdown by Application (2018-2029)
4 In Vivo Toxicology Competition Analysis by Players
4.1 Global In Vivo Toxicology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vivo Toxicology as of 2022)
4.3 Date of Key Players Enter into In Vivo Toxicology Market
4.4 Global Top Players In Vivo Toxicology Headquarters and Area Served
4.5 Key Players In Vivo Toxicology Product Solution and Service
4.6 Competitive Status
4.6.1 In Vivo Toxicology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific In Vivo Toxicology Products, Services and Solutions
5.1.4 Thermo Fisher Scientific In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Danaher
5.2.1 Danaher Profile
5.2.2 Danaher Main Business
5.2.3 Danaher In Vivo Toxicology Products, Services and Solutions
5.2.4 Danaher In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.2.5 Danaher Recent Developments
5.3 Charles River Laboratories
5.3.1 Charles River Laboratories Profile
5.3.2 Charles River Laboratories Main Business
5.3.3 Charles River Laboratories In Vivo Toxicology Products, Services and Solutions
5.3.4 Charles River Laboratories In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.3.5 Labcorp Recent Developments
5.4 Labcorp
5.4.1 Labcorp Profile
5.4.2 Labcorp Main Business
5.4.3 Labcorp In Vivo Toxicology Products, Services and Solutions
5.4.4 Labcorp In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.4.5 Labcorp Recent Developments
5.5 The Jackson Laboratory
5.5.1 The Jackson Laboratory Profile
5.5.2 The Jackson Laboratory Main Business
5.5.3 The Jackson Laboratory In Vivo Toxicology Products, Services and Solutions
5.5.4 The Jackson Laboratory In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.5.5 The Jackson Laboratory Recent Developments
5.6 Data Sciences International
5.6.1 Data Sciences International Profile
5.6.2 Data Sciences International Main Business
5.6.3 Data Sciences International In Vivo Toxicology Products, Services and Solutions
5.6.4 Data Sciences International In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.6.5 Data Sciences International Recent Developments
5.7 Envigo
5.7.1 Envigo Profile
5.7.2 Envigo Main Business
5.7.3 Envigo In Vivo Toxicology Products, Services and Solutions
5.7.4 Envigo In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.7.5 Envigo Recent Developments
5.8 Eurofins Scientific
5.8.1 Eurofins Scientific Profile
5.8.2 Eurofins Scientific Main Business
5.8.3 Eurofins Scientific In Vivo Toxicology Products, Services and Solutions
5.8.4 Eurofins Scientific In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.8.5 Eurofins Scientific Recent Developments
5.9 Perkinelmer
5.9.1 Perkinelmer Profile
5.9.2 Perkinelmer Main Business
5.9.3 Perkinelmer In Vivo Toxicology Products, Services and Solutions
5.9.4 Perkinelmer In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.9.5 Perkinelmer Recent Developments
5.10 SRI International
5.10.1 SRI International Profile
5.10.2 SRI International Main Business
5.10.3 SRI International In Vivo Toxicology Products, Services and Solutions
5.10.4 SRI International In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.10.5 SRI International Recent Developments
5.11 Taconic Biosciences
5.11.1 Taconic Biosciences Profile
5.11.2 Taconic Biosciences Main Business
5.11.3 Taconic Biosciences In Vivo Toxicology Products, Services and Solutions
5.11.4 Taconic Biosciences In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.11.5 Taconic Biosciences Recent Developments
5.12 Wuxi Apptec
5.12.1 Wuxi Apptec Profile
5.12.2 Wuxi Apptec Main Business
5.12.3 Wuxi Apptec In Vivo Toxicology Products, Services and Solutions
5.12.4 Wuxi Apptec In Vivo Toxicology Revenue (US$ Million) & (2018-2023)
5.12.5 Wuxi Apptec Recent Developments
6 North America
6.1 North America In Vivo Toxicology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In Vivo Toxicology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Toxicology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vivo Toxicology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Toxicology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vivo Toxicology Market Dynamics
11.1 In Vivo Toxicology Industry Trends
11.2 In Vivo Toxicology Market Drivers
11.3 In Vivo Toxicology Market Challenges
11.4 In Vivo Toxicology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock